A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/18/2011	WO2011100282A2 Imatinib mesylate polymorphs
08/18/2011	WO2011100267A1 Liquid composition comprising a non-menthol cooling agent and a thickener for treating a respiratory symptom
08/18/2011	WO2011100227A1 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity
08/18/2011	WO2011100209A2 Magnetically sensitive drug carriers for treatment or targeted delivery
08/18/2011	WO2011100090A1 Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
08/18/2011	WO2011099980A1 Use of the lactosylceramide synthase isoform b1, 4galt-v as a biomarker for cancer
08/18/2011	WO2011099978A1 Chromone inhibitors of s-nitrosoglutathione reductase
08/18/2011	WO2011099947A1 A new class of highly apoptotic anti-cancer agents
08/18/2011	WO2011099942A1 New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
08/18/2011	WO2011099894A1 Agent which reduces the desire to smoke
08/18/2011	WO2011099886A1 Β-carbonyl derivatives having anti-tuberculosis activity
08/18/2011	WO2011099872A1 Methods for improving sperm functionality
08/18/2011	WO2011099832A2 Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
08/18/2011	WO2011099804A2 Novel antifungal triazole derivatives
08/18/2011	WO2011099764A2 Novel pyrimidine derivative for inhibiting the growth of cancer cells
08/18/2011	WO2011099602A1 Porphyrin derivative and use thereof in radiation induced photodynamic therapy
08/18/2011	WO2011099576A1 Aptamer to fgf2 and use thereof
08/18/2011	WO2011099573A1 Extended release preparation
08/18/2011	WO2011099570A1 Age production inhibitor
08/18/2011	WO2011099507A1 Salt of fused heterocyclic derivative and crystal thereof
08/18/2011	WO2011099502A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf)
08/18/2011	WO2011099305A1 5-ht4 receptor agonists for the treatment of dementia
08/18/2011	WO2011099039A1 Process for the preparation of alpha form of imatinib mesylate
08/18/2011	WO2011099031A1 Active antioxidants for all age group
08/18/2011	WO2011099029A1 A novel boswellia low polar gum resin extract and its synergistic compositions
08/18/2011	WO2011099018A1 Polymorphs of bortezomib
08/18/2011	WO2011098971A1 Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
08/18/2011	WO2011098962A2 Anionic polysaccharides functionalised by at least two hydrophobic groups supported by an at least trivalent spacer
08/18/2011	WO2011098938A1 Novel solvate of dexlansoprazole
08/18/2011	WO2011098839A2 Di-aspirin derivatives
08/18/2011	WO2011098809A1 Sanglifehrin based compounds
08/18/2011	WO2011098808A1 Sanglifehrin based compounds
08/18/2011	WO2011098805A1 Sanglifehrin based compounds
08/18/2011	WO2011098801A1 Inflammatory disease treatment
08/18/2011	WO2011098799A2 Respiratory disease treatment
08/18/2011	WO2011098776A1 5-ht receptor modulators
08/18/2011	WO2011098746A1 Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
08/18/2011	WO2011098689A2 Use of agomelatine for the preparation of drugs for treating obsessive compulsive disorder (ocd)
08/18/2011	WO2011098610A1 Carbonic anhydrase inhibitors
08/18/2011	WO2011098607A1 Salts and hydrates of 4-[(3-chlor-4-fluoro-phenyl)amino]-6-(cis-4-{n-[(morph-1-olino-4-yl)carbonyl]-n-methyl-amino}-cyclohexane-1-yloxy)-7-methoxy-quinazoline, their use as drugs and their production
08/18/2011	WO2011098603A1 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors
08/18/2011	WO2011098582A2 Novel forms of ivabradine hydrochloride
08/18/2011	WO2011098553A1 Preparation process of the sodium salt of esomeprazole
08/18/2011	WO2011098545A1 Novel 2-methyl-1,4-naphthoquinone derivatives and precursors thereof, having vitamin k activity
08/18/2011	WO2011098539A1 Treatment of loss of sense of touch with saxitoxin derivatives
08/18/2011	WO2011098536A1 Prasugrel in micronized, crystalline form and pharmaceutical composition thereof
08/18/2011	WO2011098519A1 Homoarginine as a biomarker for the risk of mortality
08/18/2011	WO2011098483A1 Pharmaceutical compositions comprising a combination of metformin and sitagliptin
08/18/2011	WO2011098456A1 Safinamide in the treatment of dyskinesia
08/18/2011	WO2011098452A1 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
08/18/2011	WO2011098451A1 Purine derivatives and their pharmaceutical uses
08/18/2011	WO2011098448A1 Use of isorhamnetin triglycosides
08/18/2011	WO2011098433A1 Cyclic keto-enols for therapy
08/18/2011	WO2011098408A2 Hydrazine-substituted anthranilic acid derivatives
08/18/2011	WO2011098398A1 Substituted pyrrolidine-2-carboxamides
08/18/2011	WO2011098391A1 A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation
08/18/2011	WO2011098262A2 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
08/18/2011	WO2011098194A2 Pharmaceutical mini-tablets for sustained release of flecainide acetate
08/18/2011	WO2011098035A1 Sinomenine derivatives, synthetic methods and uses thereof
08/18/2011	WO2011097958A1 Oral carbapenem compounds containing aminosulfonyl azetidinyl
08/18/2011	WO2011097950A1 6-o-methylerythromycin 9-o-(3-hetroaryl-2-propenyl) oxime ketolide derivatives, preparation methods and pharmaceutical compositions thereof
08/18/2011	WO2011097946A1 Oxazolidinone compounds containing ring-fused bicyclic ring, preparation method and use thereof
08/18/2011	WO2011097857A1 Antihypertensive pharmaceutical composition
08/18/2011	WO2011097797A1 Polyphenol acrylic acid derivative, preparation and use in preparing medicine thereof
08/18/2011	WO2011097788A1 Use of pentoxifylline for preventing or treating constipation
08/18/2011	WO2011097717A1 Synthesis of bicyclic compounds and method for their use as therapeutic agents
08/18/2011	WO2011097712A1 Hybrid molecule having mixed retinoic acid receptor agonism and histone deacetylase inhibitory properties
08/18/2011	WO2011097691A1 Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol
08/18/2011	WO2011090740A9 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
08/18/2011	WO2011082267A8 Substituted triazolo-pyrazine compounds
08/18/2011	WO2011080751A3 α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
08/18/2011	WO2011079249A3 Vitamin d glycosides and sulfates for treating diseases
08/18/2011	WO2011079234A3 Highly permeating terbinafine formulation for treating onychomycosis
08/18/2011	WO2011077252A3 Metaxalone cocrystals
08/18/2011	WO2011077043A3 Phenol derivatives and pharmaceutical or cosmetic use thereof
08/18/2011	WO2011076923A9 Inhibitor for inosine monophosphate (imp) dehydrogenase and/or viral rna polymerase for treatment of hepatitis e
08/18/2011	WO2011076749A3 Solid pharmaceutical dosage form of ticagrelor
08/18/2011	WO2011072336A8 Antiviral agents
08/18/2011	WO2011072082A3 Modulation of hsp47 expression
08/18/2011	WO2011061554A3 Pharmaceutical composition for the treatment of bladder disorders
08/18/2011	WO2011057220A9 Compositions and methods for treating lymphoma
08/18/2011	WO2011056930A9 Fragile x mental retardation protein (fmrp), compositions, and methods related thereto
08/18/2011	WO2011050099A3 Therapeutic composition
08/18/2011	WO2011047341A3 Treatment of suicidal ideation or behavior using inhibitors of nicotinic acetylcholine receptors
08/18/2011	WO2011047323A3 Antimicrobial compounds and methods of making and using the same
08/18/2011	WO2011047320A3 Antimicrobial compounds and methods of making and using the same
08/18/2011	WO2011047319A3 Antimicrobial compounds and methods of making and using the same
08/18/2011	WO2011047309A9 Treatment of ischemic tissue
08/18/2011	WO2011046991A3 Certain substituted ureas as modulators of kinase activity
08/18/2011	WO2011046946A3 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
08/18/2011	WO2011044535A3 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
08/18/2011	WO2011044505A3 Enzyme inhibiting compounds and methods
08/18/2011	WO2011044499A3 Enterotoxigenic e. coli fusion protein vaccines
08/18/2011	WO2011044264A9 Pyrrolopyrazoles for treating cns disorders
08/18/2011	WO2011044230A9 N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions
08/18/2011	WO2011041737A3 Gain-of-function bcl-2 inhibitors
08/18/2011	WO2011041694A3 Compounds as lysophosphatidic acid receptor antagonists
08/18/2011	WO2011041632A3 Combination therapies for the treatment of obesity
08/18/2011	WO2011041399A3 Pi3k (delta) selective inhibitors
08/18/2011	WO2011041311A3 Compositions and methods for inhibiting inflammation from and rejection of biomaterials and other methods

1 ... 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 ... 7860